No device won in a 36-patient pilot for moderate-to-severe inflammatory acne. Intense pulsed light (IPL), pulsed dye laser (PDL) and Q-switched 1064-nm Nd:YAG each improved lesions, with no clear gap between them. Here inflammatory acne means red bumps, tender pimples and pus-filled spots. For adults with persistent acne, the practical read is narrow: no proven advantage, not proven sameness.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did the three-way pilot find?
- Did daily life improve?
- How did comfort and side effects compare?
- How does this fit the wider evidence?
- How can adults avoid overreading the headline?
What did the three-way pilot find?
The trial assigned adults with moderate-to-severe inflammatory acne to IPL, PDL or Q-switched 1064-nm Nd:YAG. Lesion counts and severity scores improved inside each arm, but differences between arms were not significant, according to the U.S. National Library of Medicine PubMed record the PubMed trial record.
That pattern matters. Improvement during treatment does not identify a best device. A small pilot can show change in every group while leaving the comparison unresolved.
Did daily life improve?
Yes, on average. In the same PubMed-record trial, Cardiff Acne Disability Index scores fell significantly in all three arms.
That index tracks acne-related disability and daily burden. Lower scores mean less interference, embarrassment and distress from breakouts. The gain appeared with IPL, PDL and Nd:YAG alike.
How did comfort and side effects compare?
The same trial record reported minimal adverse effects, with mild redness in one PDL participant. The Q-switched Nd:YAG arm reported less procedural pain than IPL or PDL.
A separate 34-patient split-face trial in skin phototypes III-IV with mild-to-moderate facial acne found 1064-nm long-pulsed Nd:YAG and 595-nm PDL equally reduced inflammatory lesions and redness, with fewer adverse effects and greater patient preference for Nd:YAG, according to the 2020 trial record the split-face trial record. Comfort is still individual, but pain and redness deserve direct questions at consultation.
How does this fit the wider evidence?
A systematic review of 18 IPL, 9 PDL and 10 Nd:YAG studies found IPL lesion reductions of 42.40%-61.56%, PDL reductions up to 82.5%, and combined PDL/Nd:YAG reductions up to 83.5%, according to the Springer Lasers in Medical Science review the Springer review of light and laser studies. Those are study ranges, not promises for any clinic.
The American Academy of Dermatology 2024 acne guideline states evidence is insufficient to recommend laser and light devices for routine acne and conditionally recommends against adding broadband light/IPL to adapalene 0.3% gel, according to the Academy update via Newswise the Academy guideline update. Device results do not replace proven topical or oral care.
How can adults avoid overreading the headline?
The headline limit is size and design. Only 36 patients were split across three arms, follow-up was short, and there was no placebo comparison, as described in that PubMed trial design.
That setup cannot prove equivalence or superiority. Use the pilot as a prompt for careful next steps, not a reason to switch or spend:.
- Keep prescribed topical or oral treatment unless your dermatologist changes it.
- Do not pay out-of-pocket for a "winner" based on a no-difference result.
- Ask what lesion type, skin type, sessions, cost, pain control and follow-up apply to you.
- Track counts, redness, pain days and missed activities for 8-12 weeks before judging benefit.
You Might Also Like
- Microneedle Radiofrequency With Low-Dose Isotretinoin in 2026: How Adults With Persistent Acne Can Avoid Overreading the Headline
- Treatment Response in the 2026 Cumulative Isotretinoin Dose Trial: How Adults With Persistent Acne Can Avoid Overreading the Headline
- Concurrent Acne Procedures and Isotretinoin in 2026 Research: How Adults With Persistent Acne Can Avoid Overreading the Headline